-+ 0.00%
-+ 0.00%
-+ 0.00%

Helsinn Healthcare Wins UK Approval for Akynzeo Oral Suspension

MT Newswires·10/29/2026 06:58:47
Listen to the news
06:58 AM EDT, 10/29/2026 (MT Newswires) -- Helsinn Healthcare secured approval from the UK Medicines and Healthcare products Regulatory Agency for the oral suspension of Akynzeo. The Switzerland-based pharmaceutical company said Thursday that the drug prevents acute and delayed nausea and vomiting tied to highly emetogenic cisplatin-based cancer chemotherapy and moderately emetogenic cancer chemotherapy in adults.